KLF2 Antibody (CL14502)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26859
Key Product Details
Validated by
Orthogonal Validation
Species Reactivity
Validated:
Human
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # CL14502
Concentration
1 mg/ml
Product Summary for KLF2 Antibody (CL14502)
Immunogen
This antibody was developed against a Synthetic Peptide of Q9Y5W3. Actual immunogen sequence is proprietary.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for KLF2 Antibody (CL14502)
Immunohistochemistry-Paraffin: KLF2 Antibody (CL14502) [NBP3-26859]
Staining of human heart muscle shows moderate to strong nuclear positivity in cardiomyocytes.
Western Blot: KLF2 Antibody (CL14502) [NBP3-26859]
Western blot analysis in human cell line CAPAN-2.
Applications for KLF2 Antibody (CL14502)
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
2-10 ug/ml
Immunohistochemistry
1:500 - 1:1000
Western Blot
1 ug/ml
Application Notes
ICC/IF Fixation Permeabilization: Use PFA/Triton X-100. For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: KLF2
Long Name
Kruppel-Like Factor 2
Alternate Names
LKLF
Gene Symbol
KLF2
Additional KLF2 Products
Product Documents for KLF2 Antibody (CL14502)
Product Specific Notices for KLF2 Antibody (CL14502)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...